Responded by: 6th September 2016
Could you please provide me with the details of any prescribing rebate schemes and QIPP prescribing schemes active within your CCG during the financial year 2015/16?
Please answer the questions below:
1. Primary Care Prescribing Rebate Schemes
Name of Scheme | Drug(s) covered | Companies involved in the scheme |
Rebate Scheme | Rivaroxaban | Bayer |
Rebate Scheme | Glucophage SR | Merck |
Rebate Scheme | Pradaxa | Boheringer Ingelheiml |
Rebate Scheme | Fluticasone/salmeterol | GSK |
Rebate Scheme | Fentanyl | Ashbourne Pharmaceuticals |
Rebate Scheme | Quetiapine | Ashbourne Pharmaceuticals |
Rebate Scheme | Nutritional Supplements | Fresenius |
Rebate Scheme | Mesalazine | Tillots |
Rebate Scheme | Leuprorelin | Takeda UK |
Rebate Scheme | Goserelin | Astra Zenica |
Rebate Scheme | Budesonide/fomoterol and fomoterol | Astra Zenica |
2. What was the total income for the CCG from rebates during 2015/16?£163,040.32.
3. QIPP Prescribing Schemes
Name of Scheme |
Drug(s) covered |
Continuous Improvement Programme |
Pregabalin |
Continuous Improvement Programme |
Buprenorphine |
Continuous Improvement Programme |
Oxycodone |
Continuous Improvement Programme |
Venlafaxine |
Continuous Improvement Programme |
Levothyroxine |
Continuous Improvement Programme |
Propranolol |
Continuous Improvement Programme |
GLP 1 inhibitors |
Continuous Improvement Programme |
Fluticasone salmeterol inhalers |
Continuous Improvement Programme |
Quetiapine |
Continuous Improvement Programme |
Alogliptin |
Continuous Improvement Programme |
Metformin MR |
Continuous Improvement Programme |
Solifenacin |
Continuous Improvement Programme |
Dutasteride |
Continuous Improvement Programme |
Melatonin |
Continuous Improvement Programme |
Fentanyl |
The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988. You are free to use it for your own purposes, including any non-commercial research you are doing and for the purposes of news reporting. Any other reuse, for example commercial publication, would require the permission of the copyright holder. Most documents supplied by NHS Stockport Clinical Commissioning Group will have been produced by Government officials and will be Crown Copyright.